BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16490174)

  • 1. Curcumin inhibits WT1 gene expression in human leukemic K562 cells.
    Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Chanarat P; Limtrakul P
    Acta Pharmacol Sin; 2006 Mar; 27(3):360-6. PubMed ID: 16490174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W; Maute L; Wicht J; Bergmann L
    Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
    Anuchapreeda S; Tima S; Duangrat C; Limtrakul P
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):585-94. PubMed ID: 18034345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells.
    Semsri S; Krig SR; Kotelawala L; Sweeney CA; Anuchapreeda S
    FEBS Lett; 2011 Jul; 585(14):2235-42. PubMed ID: 21658388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines.
    Mi Y; Wang L; Bian S; Meng Q; Chen G; Wang J
    Chin Med J (Engl); 1999 Aug; 112(8):705-8. PubMed ID: 11601276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
    Wu X; Wang Y; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):631-3. PubMed ID: 11721364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells.
    Anuchapreeda S; Limtrakul P; Thanarattanakorn P; Sittipreechacharn S; Chanarat P
    Arch Pharm Res; 2006 Jan; 29(1):80-7. PubMed ID: 16491848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
    Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
    Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
    Lv BH; Zhang L; Zhu CC; Liu J
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
    Wu X; Wang Y; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
    Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
    Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
    Sugiyama H
    Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of WT1 expression in bone marrow of acute leukemia patients with real-time quantitative RT-PCR].
    Gu WY; Chen ZX; Cao XS; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):728-31. PubMed ID: 15730716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
    Deng G; Yu JH; Ye ZQ; Hu ZQ
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of curcumin on STAT5 signaling molecule in K562 cells].
    Chen WH; Chen Y; Gu JX; He J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):151-3. PubMed ID: 15182583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
    Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ
    Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.